Here are relevant reports on : gene-therapy-market
-
Artificial Intelligence in Genomics Market by Offering (Software & Services), Technology (Machine Learning), Functionality (Gene Sequencing, Gene Editing), Application (Diagnostics, Drug discovery), End User (Pharma, Hospitals) - Global Forecast to 2028
The global artificial intelligence in genomics market, valued at US$0.4 billion in 2022, stood at US$0.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2028, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The growth in this market is predominantly driven by the need to accelerate processes and timelines, reduce costs of drug development and discovery, and improve computing power through declining hardware costs.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) & Region - Global Forecasts to 2024
The cardiac resynchronization therapy market is projected to reach USD 5.1 billion by 2024, at a CAGR of 4.4%. The growth of the Cardiac Resynchronization Therapy Market is majorly driven by the increasing incidence of target diseases (primarily due to the rising geriatric population). Rising investments and support, along with technological advancements, are also contributing to the growth of this market. Prominent players in the Cardiac Resynchronization Therapy Market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Gene Prediction Tools Market - Global Forecast to 2030
Gene Prediction Tools Market
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)
The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.
- Published: May 2011
- Price: $ 4950
- TOC Available:
-
North American Home Healthcare Market By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017
The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017
The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) - Global Forecast to 2028
The global particle therapy market, valued at US$0.6 billion in 2022, stood at US$0.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.2% from 2023 to 2028, culminating in a forecasted valuation of US$1.1 billion by the end of the period. Many factors, such as technological advancements, funding and reimbursement, strong healthcare funding, active research funding, a clear regulatory framework, growing minimally invasive procedure adoption, and the presence of key market players in developing regions are driving the growth of the particle therapy market
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Cardiovascular Therapy - Advanced Technologies And Global Market (2012 - 2017)
The research report outlines the latest developments in the cardiovascular therapy industry across the globe. The market data includes innovative technologies, key players, market trends and opportunities, drivers and challenges are clearly identified and examined.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Photodynamic Therapy Market - 2019 By Types, Application & Geography
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecasts to 2023
The global gene panel market is expected to reach USD 2.95 Billion by 2023, at a CAGR of 19.2%. The growth of this market is mainly driven by the increasing prevalence of chronic diseases, growing company initiatives, and rising adoption of gene panel owing to the benefits they offer. The gene panel market is fragmented, with the presence of several large as well as emerging players. Prominent players in the gene panels market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US). Players in this market are adopting various organic and inorganic strategies, such as product launches & upgradations, agreements, partnerships, joint ventures, collaborations, and acquisition to widen their product portfolios and expand their presence in the market.
- Published: May 2018
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
